Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Prelude Security RMP is a commercial endpoint detection and response tool by Prelude Security. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Mid-market and enterprise security teams with Windows-heavy environments will get the most from Prelude Security RMP because it catches in-memory malicious code execution that standard endpoint agents let through by collecting hardware-focused telemetry at the edge. The user-mode agent deploys without kernel modifications, reducing friction in locked-down environments, and the queryless search for endpoint activity means your SOC doesn't need new search skills to hunt what it finds. Skip this if you need cross-platform coverage or use macOS and Linux as primary targets; RMP is Windows-specific and won't give you parity across your fleet.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise security teams with Windows-heavy environments will get the most from Prelude Security RMP because it catches in-memory malicious code execution that standard endpoint agents let through by collecting hardware-focused telemetry at the edge. The user-mode agent deploys without kernel modifications, reducing friction in locked-down environments, and the queryless search for endpoint activity means your SOC doesn't need new search skills to hunt what it finds. Skip this if you need cross-platform coverage or use macOS and Linux as primary targets; RMP is Windows-specific and won't give you parity across your fleet.
Tool that immunizes Windows systems against critical vulnerabilities
Endpoint agent detecting in-memory malicious code execution on Windows.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Prelude Security RMP for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Prelude Security RMP: Endpoint agent detecting in-memory malicious code execution on Windows. built by Prelude Security. Core capabilities include Detection of malicious in-memory code execution, Hardware-focused telemetry collection, Asynchronous processing at the edge..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Prelude Security RMP differentiates with Detection of malicious in-memory code execution, Hardware-focused telemetry collection, Asynchronous processing at the edge.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Prelude Security RMP is developed by Prelude Security. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
360 High-Risk Vulnerability Immunization Tool V2.0 and Prelude Security RMP serve similar Endpoint Protection Platform use cases: both cover Windows Security. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox